Effect of the nitric oxide donor and the nitric oxide synthase inhibitor on the liver of rats with chronic hepatitis induced by dimethylnitrosamine

• Published in: Polish journal of pharmacology Vol. 56; no. 5; p. 599
• Main Authors: Lukivskaya, O, Lis, R, Zwierz, K, Buko, V
• Format: Journal Article
• Language: English
• Published: Poland 01-09-2004
• Subjects: Animals; Chemical and Drug Induced Liver Injury - drug therapy; Chemical and Drug Induced Liver Injury - metabolism; Dimethylnitrosamine - toxicity; Hepatitis, Chronic - drug therapy; Hepatitis, Chronic - metabolism; Liver - drug effects; Liver - metabolism; Male; Nitric Oxide Donors - pharmacology; Nitric Oxide Donors - therapeutic use; Nitric Oxide Synthase - antagonists & inhibitors; Nitric Oxide Synthase - metabolism; Nitroarginine - pharmacology; Nitroarginine - toxicity; Rats; Rats, Wistar
• ISSN: 1230-6002

The present study was designed to examine the effects of the donor of nitric oxide (NO), NaNO(2) and the inhibitor of NO synthase, N(omega)-nitro-L-arginine (L-NNA), on the development of dimethylnitrosamine (DMNA)-induced chronic hepatitis in rats. L-NNA decreased rat survival and enhanced the severity of hepatic encephalopathy in the DMNA-treated animals. The aggravation of the morphological signs of hepatitis, the activation of serum alanine aminotransferase and cytosolic superoxide dismutase activities and the increase in the liver malondialdehyde content were observed in this group. The treatment with NaNO(2) improved liver morphology, decreased serum marker enzyme activities, lowered the activities of alpha-D-mannosidase and N-acetyl-beta-D-glucosaminidase compared to the DMNA-treated group. The results of the morphological and biochemical studies suggest that L-NNA increased DMNA-induced liver damage, whereas NaNO(2) partially prevented the development of chronic hepatitis. It is proposed that the opposite effects of L-NNA and NaNO(2) are partially explained by a modulation of the free radical-dependent processes in the liver.